RESECTABLE PANCREATIC ADENOCARCINOMA
Clinical trials for RESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Timing of chemo could be key in pancreatic cancer fight
Disease control OngoingThis study tests whether giving chemotherapy both before and after surgery (perioperative) works better than giving it only after surgery (adjuvant) for people with pancreatic cancer that can be surgically removed. About 358 participants will receive a combination of standard che…
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 17, 2026 05:46 UTC
-
Promising cocktail targets pancreatic tumors before surgery
Disease control OngoingThis study tests a combination of chemotherapy (gemcitabine, nab-paclitaxel) and two immunotherapy drugs (durvalumab, oleclumab) given before surgery to people with pancreatic cancer that can be removed. The goal is to shrink the tumor and improve the body's immune response. Abou…
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC